Portfolio company
Orgonex
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Orgonex develops automated bioreactor systems for organoid cultivation to assist researchers and pharmaceutical companies with large-scale cell expansion and drug development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
Organo-ID
The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.
Prometheus Life Technologies
The company produces human tissue organoids in microgravity for pharmaceutical researchers to improve drug development, testing and regenerative medicine.
Unicorn Bio
This company develops automated cell culture systems and bioreactors for researchers and manufacturers in the therapeutics and cultivated meat industries.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
Scinus Group
This company develops automated, closed bioreactor systems for large-scale cell expansion, serving the cell therapy and regenerative medicine industries.
Stämm Biotech
This company develops automated microfluidic bioreactors for continuous production of biologics and cell therapies for pharmaceutical, biotechnology and cultivated meat organisations.
